Publicaciones en colaboración con investigadores/as de University of Bristol (12)

2022

  1. 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

    Annals of the rheumatic diseases, Vol. 81, Núm. 1, pp. 34-40

2021

  1. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 698-706

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Epigenetic programming of water drinking and sodium intake

    Handbook of Nutrition, Diet, and Epigenetics (Springer International Publishing), pp. 1307-1327

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients

    Annals of the Rheumatic Diseases

  2. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1

    Nature Communications, Vol. 6

  3. Minimum Information about a Biosynthetic Gene cluster

    Nature Chemical Biology, Vol. 11, Núm. 9, pp. 625-631

2013

  1. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

    Nature Genetics, Vol. 45, Núm. 7, pp. 730-738

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    Nature Genetics, Vol. 43, Núm. 8, pp. 761-767